Carbapenem-Resistant Enterobacteriaceae (CRE) is an urgent antibiotic resistant threat according to the Centers for Disease Control and Prevention. Infections caused by these bacteria are hard-to-treat and this type of resistance can easily move from one bacterium to another. Preventing infections is a high priority and laboratory detection is a key feature of any successful prevention program. In this on-demand webinar Dr. Jean Patel will review laboratory methods for detecting and characterizing CRE for:
- Therapy decisions
- Infection prevention
- Surveillance studies
Presenter: Jean B. Patel, Ph.D., D (ABMM)
Dr. Jean Patel currently serves as the principal scientist, scientific affairs, at Beckman Coulter. Prior to her role at Beckman Coulter, Dr. Patel served as the science team lead, antibiotic resistance coordination and strategy unit, at the Centers for Disease Control (CDC), where she led implementation of its Antibiotic Resistance Laboratory Network and the CDC and FDA Antibiotic Resistance Isolate Bank.
Dr. Patel has served as chair and vice chair of the Clinical and Laboratory Standards Institute Subcommittee for Antimicrobial Susceptibility Testing and works with the World Health Organization (WHO) to develop technical guidance for detecting resistance and strengthening global surveillance of antimicrobial resistance